Widefield retinal imaging involves imaging of peripheral retina, which is the primary site of several ocular diseases. Widefield imaging helps in management of peripheral retina diseases. These systems are capable of producing wide, and ultra wide colored fundus photographs, fluorescein and indocyanine green angiograms, and autofluorescence images. Important ophthalmic diseases such as diabetic retinopathy, retinal vascular occlusions and tumors, age-related macular degeneration, and others can be effectively diagnosed and managed using wide field imaging technology. Examples of widefield microscopy techniques are brightfield, differential interference contrast (DIC), phase contrast, and widefield fluorescence. Brightfield microscopy is an accessible form of microscopy, where an entire sample is illuminated by a bright light. Widefield microscopy generally refers to the use of a microscope not equipped with a pinhole (see Confocal Microscopy) in the detection path. These microscopes can be used for capturing both transmitted light images (phase contrast, DIC, and others) as well as fluorescent images. In a diabetic eye, UWF imaging allows immediate recognition of the degree and severity of DR and the extent of the ischemic retinal areas in the posterior pole, the equator, and the peripheral retina—all at the same time, in a single plane, and after a single shot. The retina covers 72% of the inside of the eye globe [4], or roughly 180° visual field. MRI has proved to be the most sensitive technique for evaluating retinoblastoma, especially regarding tumor infiltration of the optic nerve, extraocular extension and intracranial disease.
Market Dynamics
Increasing adoption of organic growth strategies, such as product launch by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in April 2022, Optos Plc, a company that provides high-resolution ultra-widefield retinal imaging and image-guided Optical Coherence Tomography (OCT) devices for eye care professionals announces the launch of the first CE-marked AI-based solution to automate the detection of more-than-mild diabetic retinopathy (DR) and diabetic macular odema, both vision-threatening diseases, using optomap ultra-widefield retinal images.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 35 market data tables and 34 figures on “Global Widefield Imaging Systems Market” - Global forecast to 2030
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients